Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Short-term changes in added sugar consumption by adolescents reflected in the carbon isotope ratio of fingerstick blood.

Liu SV, Moore LB, Halliday TM, Jahren AH, Savla J, Hedrick VE, Marinik EL, Davy BM.

Nutr Health. 2018 Sep 20:260106018799522. doi: 10.1177/0260106018799522. [Epub ahead of print]

PMID:
30231801
2.
3.

Urinary Excretion of Sodium, Nitrogen, and Sugar Amounts Are Valid Biomarkers of Dietary Sodium, Protein, and High Sugar Intake in Nonobese Adolescents.

Moore LB, Liu SV, Halliday TM, Neilson AP, Hedrick VE, Davy BM.

J Nutr. 2017 Dec;147(12):2364-2373. doi: 10.3945/jn.117.256875. Epub 2017 Sep 20.

4.

Nanoparticle delivery of miR-223 to attenuate macrophage fusion.

Moore LB, Sawyer AJ, Saucier-Sawyer J, Saltzman WM, Kyriakides TR.

Biomaterials. 2016 May;89:127-35. doi: 10.1016/j.biomaterials.2016.02.036. Epub 2016 Feb 26.

5.

Molecular Characterization of Macrophage-Biomaterial Interactions.

Moore LB, Kyriakides TR.

Adv Exp Med Biol. 2015;865:109-22. doi: 10.1007/978-3-319-18603-0_7. Review.

6.

Loss of monocyte chemoattractant protein-1 alters macrophage polarization and reduces NFκB activation in the foreign body response.

Moore LB, Sawyer AJ, Charokopos A, Skokos EA, Kyriakides TR.

Acta Biomater. 2015 Jan;11:37-47. doi: 10.1016/j.actbio.2014.09.022. Epub 2014 Sep 19.

7.

Toxocariasis in North America: a systematic review.

Lee RM, Moore LB, Bottazzi ME, Hotez PJ.

PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3116. doi: 10.1371/journal.pntd.0003116. eCollection 2014 Aug. Review.

8.

Inflammasome components Asc and caspase-1 mediate biomaterial-induced inflammation and foreign body response.

Malik AF, Hoque R, Ouyang X, Ghani A, Hong E, Khan K, Moore LB, Ng G, Munro F, Flavell RA, Shi Y, Kyriakides TR, Mehal WZ.

Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20095-100. doi: 10.1073/pnas.1105152108. Epub 2011 Nov 22.

9.

Aberration fields of a combination of plane symmetric systems.

Moore LB, Hvisc AM, Sasian J.

Opt Express. 2008 Sep 29;16(20):15655-70. Erratum in: Opt Express. 2009 Aug 17;17(17):15390-1.

PMID:
18825204
10.

The phytoestrogen coumestrol is a naturally occurring antagonist of the human pregnane X receptor.

Wang H, Li H, Moore LB, Johnson MD, Maglich JM, Goodwin B, Ittoop OR, Wisely B, Creech K, Parks DJ, Collins JL, Willson TM, Kalpana GV, Venkatesh M, Xie W, Cho SY, Roboz J, Redinbo M, Moore JT, Mani S.

Mol Endocrinol. 2008 Apr;22(4):838-57. Epub 2007 Dec 20.

11.

Divergent evolution of function in the ROK sugar kinase superfamily: role of enzyme loops in substrate specificity.

Larion M, Moore LB, Thompson SM, Miller BG.

Biochemistry. 2007 Nov 27;46(47):13564-72. Epub 2007 Nov 3.

PMID:
17979299
12.

Crystal structure of the pregnane X receptor-estradiol complex provides insights into endobiotic recognition.

Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR.

Mol Endocrinol. 2007 May;21(5):1028-38. Epub 2007 Feb 27. Erratum in: Mol Endocrinol. 2007 Jun;21(6):1488-9.

PMID:
17327420
13.

Academic health center management of chronic diseases through knowledge networks: Project ECHO.

Arora S, Geppert CM, Kalishman S, Dion D, Pullara F, Bjeletich B, Simpson G, Alverson DC, Moore LB, Kuhl D, Scaletti JV.

Acad Med. 2007 Feb;82(2):154-60.

14.

Human PXR forms a tryptophan zipper-mediated homodimer.

Noble SM, Carnahan VE, Moore LB, Luntz T, Wang H, Ittoop OR, Stimmel JB, Davis-Searles PR, Watkins RE, Wisely GB, LeCluyse E, Tripathy A, McDonnell DP, Redinbo MR.

Biochemistry. 2006 Jul 18;45(28):8579-89.

15.

Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin.

Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR.

Mol Endocrinol. 2005 May;19(5):1125-34. Epub 2005 Feb 10.

PMID:
15705662
16.

A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer.

Xu RX, Lambert MH, Wisely BB, Warren EN, Weinert EE, Waitt GM, Williams JD, Collins JL, Moore LB, Willson TM, Moore JT.

Mol Cell. 2004 Dec 22;16(6):919-28.

17.

Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells.

Clay WC, Condreay JP, Moore LB, Weaver SL, Watson MA, Kost TA, Lorenz JJ.

Assay Drug Dev Technol. 2003 Dec;1(6):801-10.

PMID:
15090226
18.

Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity.

Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG, Stimmel JB.

Biochemistry. 2003 Aug 12;42(31):9278-87. Erratum in: Biochemistry. 2006 Oct 3;45(39):12194.

PMID:
12899614
19.

Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes.

Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT.

J Biol Chem. 2003 May 9;278(19):17277-83. Epub 2003 Feb 27.

20.

2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.

Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR.

Biochemistry. 2003 Feb 18;42(6):1430-8.

PMID:
12578355
21.

Functional and structural comparison of PXR and CAR.

Moore JT, Moore LB, Maglich JM, Kliewer SA.

Biochim Biophys Acta. 2003 Feb 17;1619(3):235-8. Review.

PMID:
12573482
22.

A new series of estrogen receptor modulators that display selectivity for estrogen receptor beta.

Henke BR, Consler TG, Go N, Hale RL, Hohman DR, Jones SA, Lu AT, Moore LB, Moore JT, Orband-Miller LA, Robinett RG, Shearin J, Spearing PK, Stewart EL, Turnbull PS, Weaver SL, Williams SP, Wisely GB, Lambert MH.

J Med Chem. 2002 Dec 5;45(25):5492-505.

PMID:
12459017
23.

Use of in vitro pregnane X receptor assays to assess CYP3A4 induction potential of drug candidates.

Jones SA, Moore LB, Wisely GB, Kliewer SA.

Methods Enzymol. 2002;357:161-70. No abstract available.

PMID:
12424907
24.

Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines.

Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, Plunket KD, Morgan DG, Beaudet EJ, Whitney KD, Kliewer SA, Willson TM.

J Med Chem. 2002 May 9;45(10):1963-6.

PMID:
11985463
25.

Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors.

Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert MH, Moore JT.

Mol Endocrinol. 2002 May;16(5):977-86.

PMID:
11981033
26.

Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen.

Desai PB, Nallani SC, Sane RS, Moore LB, Goodwin BJ, Buckley DJ, Buckley AR.

Drug Metab Dispos. 2002 May;30(5):608-12.

PMID:
11950795
27.

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.

Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT Jr, McKee DD, Moore JT, Willson TM.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13919-24. Epub 2001 Nov 6.

28.

Regulation of the human CYP2B6 gene by the nuclear pregnane X receptor.

Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA.

Mol Pharmacol. 2001 Sep;60(3):427-31.

PMID:
11502872
29.

The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.

Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR.

Science. 2001 Jun 22;292(5525):2329-33. Epub 2001 Jun 14.

30.

Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha.

Spencer TA, Li D, Russel JS, Collins JL, Bledsoe RK, Consler TG, Moore LB, Galardi CM, McKee DD, Moore JT, Watson MA, Parks DJ, Lambert MH, Willson TM.

J Med Chem. 2001 Mar 15;44(6):886-97.

PMID:
11300870
31.

Production and characterization of an estrogen receptor beta subtype-specific mouse monoclonal antibody.

Su JL, McKee DD, Ellis B, Kadwell SH, Wisely GB, Moore LB, Triantafillou JA, Kost TA, Fuqua S, Moore JT.

Hybridoma. 2000 Dec;19(6):481-7.

PMID:
11152400
32.

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis.

Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, Kliewer SA.

Mol Cell. 2000 Sep;6(3):517-26.

33.

Identification of a chemical tool for the orphan nuclear receptor FXR.

Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, Creech KL, Moore LB, Wilson JG, Lewis MC, Jones SA, Willson TM.

J Med Chem. 2000 Aug 10;43(16):2971-4. No abstract available.

PMID:
10956205
34.

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.

Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA.

Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7500-2.

35.

Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands.

Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, Collins JL, Kliewer SA.

J Biol Chem. 2000 May 19;275(20):15122-7.

36.

The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution.

Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT.

Mol Endocrinol. 2000 Jan;14(1):27-39.

PMID:
10628745
37.

Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.

Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT.

Cancer Res. 1999 Nov 1;59(21):5425-8.

38.

A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activity.

Brown PJ, Winegar DA, Plunket KD, Moore LB, Lewis MC, Wilson JG, Sundseth SS, Koble CS, Wu Z, Chapman JM, Lehmann JM, Kliewer SA, Willson TM.

J Med Chem. 1999 Sep 23;42(19):3785-8. No abstract available.

PMID:
10508427
39.

A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.

Oberfield JL, Collins JL, Holmes CP, Goreham DM, Cooper JP, Cobb JE, Lenhard JM, Hull-Ryde EA, Mohr CP, Blanchard SG, Parks DJ, Moore LB, Lehmann JM, Plunket K, Miller AB, Milburn MV, Kliewer SA, Willson TM.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6102-6.

40.

Cloning and characterization of human estrogen receptor beta isoforms.

Moore JT, McKee DD, Slentz-Kesler K, Moore LB, Jones SA, Horne EL, Su JL, Kliewer SA, Lehmann JM, Willson TM.

Biochem Biophys Res Commun. 1998 Jun 9;247(1):75-8.

PMID:
9636657
41.

Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway.

Lehmann JM, Kliewer SA, Moore LB, Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA, Blanchard DE, Spencer TA, Willson TM.

J Biol Chem. 1997 Feb 7;272(6):3137-40.

42.

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones.

Willson TM, Cobb JE, Cowan DJ, Wiethe RW, Correa ID, Prakash SR, Beck KD, Moore LB, Kliewer SA, Lehmann JM.

J Med Chem. 1996 Feb 2;39(3):665-8. No abstract available.

PMID:
8576907
43.

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).

Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA.

J Biol Chem. 1995 Jun 2;270(22):12953-6.

44.

3-[4-(1,2-Diphenylbut-1-enyl)phenyl]acrylic acid: a non-steroidal estrogen with functional selectivity for bone over uterus in rats.

Willson TM, Henke BR, Momtahen TM, Charifson PS, Batchelor KW, Lubahn DB, Moore LB, Oliver BB, Sauls HR, Triantafillou JA, et al.

J Med Chem. 1994 May 27;37(11):1550-2. No abstract available.

PMID:
8201587
45.
46.

Recanalization of occluded superior vena cava for replacement of LeVeen shunt catheter.

Vujic I, Moore LB, LeVeen HH.

Radiology. 1987 Jul;164(1):270-2.

PMID:
2954184
47.

Massive hemoptysis: control by embolization of the thyrocervical trunk.

Moore LB, McWey RE, Vujic I.

Radiology. 1986 Oct;161(1):173-4.

PMID:
3763862
48.

Non-budding strains of hydra: isolation from sexual crosses and developmental regulation of form.

Moore LB, Campbell RD.

J Exp Zool. 1973 Jul;185(1):73-81. No abstract available.

PMID:
4717557
49.

Bud initiation in a non-budding strain of hydra: role of interstitial cells.

Moore LB, Campbell RD.

J Exp Zool. 1973 Jun;184(3):397-408. No abstract available.

PMID:
4708142
50.

Recombination in regions adjacent to deletions in the X chromosome of Drosophila melanogaster.

Lefevre G Jr, Moore LB.

Genetics. 1968 Apr;58(4):557-71. No abstract available.

Supplemental Content

Loading ...
Support Center